InterventionsHuman trial
Crizotinib versus observation or placebo for surgically resected early-stage ALK-positive non-small-cell lung cancer (Eastern Cooperative Oncology Group-American College of Radiology Imaging Network E4512): a phase 3 trial
The Lancet Respiratory Medicine
The paper
Gerber DE, Wang Y, Langer CJ et al.
The Lancet Respiratory Medicine · 25 Aug 2026
